Mona Bajaj

Suggest Changes
Learn More
AIMS To investigate the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in patients with Type 2 diabetes mellitus inadequately controlled by a combination of metformin and(More)
  • 1